Stefanie Lietz
Ulm, BW 89081, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Novel endogenous protein-based strategies to inhibit clinically relevant bacterial AB-type toxins including pertussis toxin.
Journal: Archives of toxicology
Published: January 19, 2026
An endogenous human peptide derived from α1-antitrypsin as a novel pharmacological inhibitor of Bordetella pertussis toxin.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: July 04, 2025
The antimicrobial peptide Angie 5 inhibits TcdA and TcdB from Clostridioides difficile.
Journal: Cellular and molecular life sciences : CMLS
Published: November 14, 2024
Alpha-1 antitrypsin inhibits Clostridium botulinum C2 toxin, Corynebacterium diphtheriae diphtheria toxin and B. anthracis fusion toxin.
Journal: Scientific reports
Published: June 19, 2024
The antiarrhythmic drugs amiodarone and dronedarone inhibit intoxication of cells with pertussis toxin.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: June 06, 2024
Alpha-1 antitrypsin inhibits pertussis toxin.
Journal: The Journal of biological chemistry
Published: May 28, 2024
Showing 1-8 of 8
Last Updated: 09/26/2026